Illumina INC:1107104 [18-057620]

Ended Awarded Last action

Contract number
75N91018F00139
Awardee
Awarding agency
Obligated
$13,044

Award facts

Opportunity
  • NIHNHLBICSBHG2015RF Solicitation number
Contract value 100% obligated
$13,043.75 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute issued a $13,043.75 delivery order to Illumina, Inc. on August 17, 2018, for genetic sequencing and genomic analysis technologies.

Place of performance is Bethesda, MD. The order has a firm fixed-price pricing structure and an ultimate completion date of September 15, 2018. Illumina manufactures advanced DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software supporting genomic research across federal agencies.

Quick answers

Who was awarded contract 75N91018F00139?

75N91018F00139 was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on August 17, 2018.

How much is contract 75N91018F00139 worth?

The government has obligated $13,044 on 75N91018F00139.

Is contract 75N91018F00139 an order under another contract?

Yes. 75N91018F00139 is a delivery order under HHSN268201500004I, an indefinite delivery contract.

Was contract 75N91018F00139 competed?

The extent of competition for 75N91018F00139 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login